Page results
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
File results
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas
-
FOI/2023/0235 - Hip and knee arthroplasty litigation
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation